Wednesday, November 29, 2006

Pain Therapeutics Phase I Study Positive

Pain Therapeutics (PTIE) announced early on Wednesday that its phase I clinical study of the abuse resistant opioid painkiller, PTI-202, showed positive results.

The study was aimed at investigating the safety and tolerability of PTI-202.

The company is focused on research and development of its opioid painkiller portfolio that exhibit non-abuse potential as compared to traditional opioids on the market.

Pain Therapeutics was chosen as a BioHealth Investor Stock Pick back on November 19.

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home

Finance Blogs - Blog Top Sites Day-Traderz Finance Directory blog search directory
Finance Blogs - Blog FlareBlog Directory & Search engine RankingBlogs.com :: Defining Your Blogs Worth: TopSites:
Blog Flux Pinger - reliable ping service.Directory of Investing BlogsBlogarama - The Blog Directory
Blog Directory
Bloggeries Blog Directory Business
Powered by WebRing.